Exibindo 1861 - 1890 de 2728
When Fiocruz joined the small summit of guest countries of the Global Sustainable Technology and Innovation Community (G-STIC) in 2018, the world still did not know Sars-CoV-2. Now, while the world population takes the vaccine for COVID-19, the fifth edition of the annual conference (the fourth with the participation of the Foundation), bets on a hybrid participation model from October 24th to 26th. The agenda includes both virtual and on-site sessions looking for new technological solutions to serve the society that are environmentally friendly and aimed at 9 of the 17 Sustainable…
Article
Would it be possible to establish a new food model without the large producers' participation? Finding this answer is an ongoing global challenge and resounded in the seminar Food security, health and pandemics in United Nations events, organized by the Fiocruz Global Health Center (CRIS/Fiocruz). Divergent analyses and opinions revealed behind the scenes of international decisions on hunger programs and inspired empathy in provocative, necessary and urgent reflections.
"Is it possible to think of an alternative food system without the large corporations' participation? In Chile, even Coca-…
Article
A cooperation that dates back to the beginning of the last century and that has been renovated and expanded over the decades was celebrated last Thursday (October 14th), with the visit of Portugal’s assistant secretary of Health, António Lacerda Sales, to Fiocruz. Accompanied by the Secretary of State of the Portuguese Communities, Berta Nunes, and by ambassador Luís Faro Ramos, among other members of the delegation, Sales was received by president Nísia Trindade Lima at the International Auditorium of the Sergio Arouca National School of Public Health (ENSP/Fiocruz), where they emphasized…
Article
After a one-year break due to the restrictions caused by the COVID-19 pandemic, the Fiocruz in Antarctica (Fioantar) project resumed its scientific excursions into the continent with a new departure this Wednesday morning (10/13). After a week of quarantine with actions to fight COVID-19, including diagnostic tests before and during the period, the Ary Rongel oceanographic support ship set sail to the Comandante Ferraz Antarctic Station carrying researcher Lucas Moreira. In November, three other Fioantar researchers - Maria Ogrzewalska, Harrison Magdinier Gomes, and Maithê Magalhães - will be…
Article
A study led by the Center for the Integration of Data and Knowledge on Health (Cidacs/Fiocruz Bahia) suggests that C-sections may be associated with a higher risk of infant mortality, with the exception of cases in which a medical indication is clear on this procedure, which is popularly known as “cesarean” in Brazil.
Photo: Courtesy
Using data collected and provided by the Ministry of Health on more than 17 million births in Brazil between 2012 and 2018, researchers from Brazil and from the United Kingdom observed that in the group with a low indication of C-section, this procedure was…
Article
Sociologist and Fiocruz president, Nísia Trindade Lima, presented last Friday (October 8th) the conference Pandemic and Social Inequalities: Challenges for Global Health. The event was part of the Global Health Colloquium Series, a biannual series of lectures by Princeton University's Program in Global Health. Nísia thanked the university and Brazil Lab for the invitation, a hub that connects researchers and professors interested in public management in the country. The mediation was by Arbela Griner, postdoctoral fellow of the Program and event organizer.
Values, total social fact, and…
Article
Fiocruz will be part, starting next week, of a Phase 3 international multicenter study with the drug Molnupiravir, manufactured by the pharmaceutical company MSD. The goal is to verify its efficiency to prevent the COVID-19 spread and transmission among people exposed to the Sars-CoV-2 virus. The study will occur simultaneously in seven centers in Brazil, two of which are under the Fiocruz responsibility: Mato Grosso do Sul and Rio de Janeiro. The coordination is under the responsibility of researchers Julio Croda and Margareth Dalcolmo.
To evaluate the Molnupiravir use as post-exposure…
Article
On Thursday (September, 30th), the project for the installation of the Pharmaceutical Plant in Maputo, Mozambique capital, was concluded. The announcement was made in a joint statement by the Brazil and Mozambique governments and is the result of the technology transfer mission and partnership with the Institute of Technology in Medicines (Farmanguinhos/Fiocruz).
"We are finishing this important project with the merit of having left the factory producing, teams trained, and a set of technologies transferred that are now part of the initial Mozambican Drug Society portfolio", said the…
Article
The ambassador of Botswana to Brazil, Tebogo Montshome, visited Fiocruz last Thursday (October 7th). She decided to get to know the Foundation while visiting Rio de Janeiro to identify areas of possible cooperation between her country and the institution. Greeted by the Vice-President of Production and Innovation in Health, Marco Krieger, Montshome was particularly interested in staff training, research and production of drugs and vaccines.
Marco Krieger, Tebogo Montshome, Sethunya Sedimo and Augusto Paulo Silva (Photo: Peter Ilicciev)
The ambassador was accompanied by the embassy's…
Article
Depois de um ano de intervalo devido às restrições provocadas pela pandemia de Covid-19, o projeto Fiocruz na Antártica (Fioantar) retomou as expedições científicas ao continente com um novo embarque na manhã desta quarta-feira (13/10). Após uma semana em quarentena com ações para enfrentamento à Covid-19, incluindo execução de testes diagnósticos antes e durante o período, o navio de apoio oceanográfico Ary Rongel partiu rumo à Estação Antártica Comandante Ferraz com o pesquisador Lucas Moreira. Em novembro, mais três pesquisadores do Fioantar - Maria Ogrzewalska, Harrison Magdinier Gomes e…
Article
With Fiocruz among the signatories, it was launched this Wednesday (October 6), the São Paulo Declaration on Planetary Health, an initiative of Planetary Health Alliance and the University of São Paulo, in partnership with the United Nations Development Programme (UNDP). The declaration is considered the first document of the global planetary health community to describe the actions needed to achieve what it calls "the great transition: a just transformation to a world that optimizes the health and all people and the planet's well-being".
Published on Wednesday in the scientific journal The…
Article
A new study by Fiocruz on the effectiveness of vaccination in Brazil shows that the population has benefitted from the vaccination plan against the Sars-CoV-2 in the prevention of severe cases and deaths by Covid-19, although effectiveness varies between age groups. The analysis, which also included subjects vaccinated with the first dose of the Pfizer shot, was carried out between January 17 and July 19 this year, a total of six months, in which the Gamma variant was predominant. The study evaluated more than 66 million records and is available in the MedRxiv online repository as preprint (…
Article
In the first decades of the twentieth century, the American multinational United Fruit Company, prominent in the production and sale of tropical fruits, found a way to deal with malnutrition among its workers in Costa Rica: it imported canned and processed foods from the United States. At the same time, the solution to high infant mortality in the banana plantation zone was the introduction of an artificial food developed by Nestlé. Years later, in Mexico, the government followed the “fortified” food trend, promoting the consumption of vitamin-enriched sugar.
No, obesity did not appear…
Article
The Institute of Drug Technology (Farmanguinhos/Fiocruz) is closer to starting Pediatric Praziquantel production, indicated for schistosomiasis, a parasitic disease that affects about 200 million people worldwide, half of whom are children. Result of the International Pediatric Praziquantel Consortium, the drug is in the clinical trials last phase. Pilot batches are expected to be produced in March 2022 and the product available in 2024.
It is a water-dispersible tablet, which facilitates its administration to children under the age of six. Until now, the medication available for this…
Article
Large-scale deforestation of the Amazon forest associated with climate change will increase the risk of exposure to extreme heat. Such levels of heat, which will be physiologically intolerable for the human body, will profoundly affect regions inhabited by highly vulnerable populations, according to a study published by researchers Beatriz Alves de Oliveira, of Fiocruz; Marcus Bottino and Paulo Nobre, both of the National Institute of Space Research (INPE); and Carlos Nobre, of the Institute for Advanced Studies of the University of São Paulo (IEA/USP). This is the first analysis of the…
Article
The Evandro Chagas National Institute of Infectious Diseases (INI/Fiocruz) is now open for enrollment, up to November 1, into the Fourth International Course on Immunohistochemistry, Molecular Pathology and Histopathology for the Diagnosis of Infectious Diseases. Coordinated by Rodrigo Caldas Menezes, Luiz Cláudio Ferreira and Leonardo Pereira Quintella, the training is aimed at healthcare professionals, especially those that work or wish to work in the field of pathological anatomy on the techniques of histopathology, immunohistochemistry and molecular pathology, focused on the…
Article
The COVID-19 pandemic was one of the main subjects discussed at two meetings that drew the attention of the entire world and of the region last week. While chiefs of state and of government debated the effects of the disease at the 76th General Assembly of the United Nations, at the 59th Board of Directors and 73rd Session of the Regional Committee of the World Health Organization (WHO) for the Americas, organized by the Pan-American Health Organization (PAHO), ministries of health discussed how to obtain a more equitable distribution of vaccines. With several issues in common, the agendas of…
Article
By means of its Immunobiological Technology Institute (Bio-Manguinhos), last Monday (September 27th) Fiocruz ended the production of the first batches called pre-validation batches of the national Active Pharmaceutical Ingredient (API) for the COVID-19 vaccine. The ingredient will now be submitted to quality control tests at the institution to then be sent to the final processing phase of the vaccine. The first pre-validation batch, which was produced early in September, is also under analysis.
The goal of the two pre-validation batches is to show that the process works as expected and, if…
Article
Mais de 5,2 milhões de crianças morreram antes que pudessem completar cinco anos no Brasil, entre 2006 e 2015. Esse número poderia ser ainda maior caso não houvesse programas de transferência de renda, como Bolsa Família, que ajudou a reduzir em 16% a mortalidade nessa faixa etária. Essa é a conclusão do estudo realizado usando métodos estatísticos e Big Data, no Centro de Integração de Dados e Conhecimento para Saúde (Cidacs/Fiocruz Bahia). O resultado foi publicado (28/9) na revista PLOS Medicine.
Os pesquisadores compararam os municípios de alta e baixa renda e entre aqueles onde há…
Article
Diseases that Brazilians are very familiar with, such as dengue fever, zika and chikungunya, are being directly affected by the pandemic, both with the transfer of human and material resources to the fight against COVID-19 and with possible undernotifications. But we can learn lessons from this experience, as shown by the 20th Advanced Seminaries on Global Health and Health Diplomacy of the Fiocruz Global Health Center (CRIS/Fiocruz), held last Thursday (September 23rd). And as indicated by the Challenges and opportunities to control arbovirus diseases in COVID-19 times webinar, this problem…
Article
The Immunobiological Technology Institute (Bio-Manguinhos/Fiocruz) was selected last Tuesday (September 21st) by the World Health Organization (WHO) as a hub for the development and production of vaccines using messenger RNA in Latin America. This Foundation unit was chosen due to the promising advancements in the technological development of an mRNA vaccine against Covid-19, currently in a pre-clinical stage. The initiative used resources of the Ministry of Health and of parliamentary amendments for its development.
The choice was the result of a worldwide call launched on April 16th, 2021…
Article
As part of the preparations for the new Brazilian expedition to Antarctica, Fiocruz donated 3,000 rapid tests to detect Sars-Cov-2 antigens to the Navy. The kits, produced by the Institute of Technology in Immunobiologicals (Bio-Manguinhos/Fiocruz), will be used to test the entire crew on board, on the support flights, the team at the Comandante Ferraz Antarctic Station and the researchers who will be part of the new trip - including the Fioantar team, which leaves in the next weeks. The Fiocruz's Antarctic program expeditions with researchers are being resumed, after the interruption last…
Article
A edição extra do Boletim Observatório Covid-19 Fiocruz, publicada nesta quarta-feira (22/9), reforça a tendência de queda no indicador de ocupação de leitos de Covid-19 para adultos. Com exceção de Espírito Santo e Distrito Federal, onde se observou crescimento, entre 13 e 20 de agosto, o indicador continua apresentando sinais de queda ou estabilização no país. Segundo dados obtidos em 20 de setembro, nenhum estado está na zona crítica, com taxa superior a 80%.
O Amazonas apresentou aumento no indicador de 29% para 50%, mas permanece fora da zona de alerta: esse crescimento…
Article
A Swedish study with people infected by the Sars-CoV-2 and with subjects immunized with the Oxford/AstraZeneca (produced in Brazil by Fiocruz), Pfizer/BioNTech vaccines, and with people who were given one dose of each vaccine shows good protection 12 months after vaccination, against the so-called variants of concern. Submitted as preprint (without peer review), the research shows that two doses of the AstraZeneca vaccine result in the smallest reduction in effectiveness in neutralization assays against the Gamma and Beta variants, those with the most significant drops in effectiveness in all…
Article
Researcher Jorge Bermudez, chief of the Department of Medicines Policy and Pharmaceutical Services at the Sergio Arouca National School of Public Health (ENSP/Fiocruz, in the Portuguese acronym), is now a member of the Technical Advisory Group (TAG) created to advise the World Health Organization (WHO) in scientific, technical and strategic issues related to COVID-19 Technology Access Pool (C-TAP). C-TAP is a solidarity mechanism launched in May 2020 to facilitate timely, accessible and equitable access to COVID-19-related technologies. The only representative of Latin America in the…
Article
Women are the majority in the healthcare workforce. Yet they are far from leadership positions, face unequal pay, and are often victims of bullying and sexual harassment. If the panorama described in the webinar Women in Global Health, promoted by the Fiocruz Global Health Center (Cris/Fiocruz) on the last 15th, seems bleak, it also brings foci of hope: at the same time that it exacerbated these inequalities, the COVID-19 pandemic shed light on them, broadening the debate around the theme and the search for solutions.
Coordinated by the Fiocruz vice-president of Education, Information…
Article
The president of Oswaldo Cruz Foundation (Fiocruz), Nísia Trindade Lima, has been appointed to the Board of the Coalition for Epidemic Preparedness Innovations (CEPI). She becomes one of two representatives for Latin America on the Board. CEPI is an international organization, that aims to fund research projects to accelerate vaccines against epidemics.
CEPI has secured funding from over thirty governments, philanthropic institutions and private sector investors to date, with other twenty-five vaccine development partnerships…
Article
Last Wednesday, September 1st, Nísia Trindade Lima, president of Fiocruz, was granted the Knight Grade of France’s Legion of Honor (Ordre National de la Légion d'Honneur). She was graced with the honor as an acknowledgment of the Foundation’s president in the fields of Science and Health, especially regarding the actions undertaken by the institution in the fight against the COVID-19 pandemic. The ceremony, which took place at Praça Pasteur, at the Fiocruz Manguinhos campus, in Rio de Janeiro, was limited to a few guests, who followed strict social distancing protocols. The honor was given to…
Article
The world is ageing, and it is not only in the wealthiest countries. In Brazil, this matter has an aggravating factor: while more developed nations become rich first and then age, Brazil is ageing in poverty, warns Alexandre Kalache. The president of the International Longevity Centre in Brazil, who is a doctor, was the mediator in the webinar Ageing, demographic changes and the pandemic, of the Fiocruz Global Health Center (CRIS/Fiocruz), that showed the impact of COVID-19 on the matter on last Wednesday (September 1st).
It is not possible to talk about the pandemic’s impact on…
Article
Despite the restrictions imposed due to the pandemic, the team at the Laboratory for Clinical Research on Mycobacterioses of the Evandro Chagas National Institute of Infectology (INI/Fiocruz) considers 2021 a year of great advances. "Besides the adaptation to work in home office and the remote service implementation for patients, we have been contemplated in different national and international initiatives. This allows us to carry out new studies to improve the tuberculosis diagnosis and treatment, which is a serious public health problem in the country", said Valeria Rolla, head of the…
Article